Abstract
Psychotic disorders such as schizophrenia are closely related to the development of obesity and metabolic perturbations. Antipsychotic medication is the mainstay of treatment of psychosis, but the drugs are associated with marked risk of metabolic side effects1. The onset of psychotic disorders typically occurs in early adulthood, and as the course of illness is often chronic, long-term or even lifelong treatment with antipsychotic medication will often be needed.